National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2022-28186"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2022-28186"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2022-12-28"
last_updated: "2022-12-28"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-28186"
document_type: "notice"
publication_date: "2022-12-28"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "87 FR 79896"
fr_volume: 87
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, TEP-8A: SBIR Contract Review, February 1, 2023, 9:30 a.m. to 5:30 p.m., National Cancer Institute at Shady Grove, Room 7W030, 9609 Medical Center Drive, Rockville, Maryland, 20850 which was published in the *Federal Register* on December 19, 2022, FR Doc 2022-27417, 87 FR 77624.

This notice is being amended to change the meeting time from 9:30 a.m.-5:30 p.m. to 10:00 a.m.-2:00 p.m. on February 1, 2023. The meeting date and location will stay the same. The meeting is closed to public.

Dated: December 21, 2022.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.